Home / Publications / Identification of natural compounds targeting SARS-CoV-2 Mpro by virtual screening and molecular dynamics simulations

Identification of natural compounds targeting SARS-CoV-2 Mpro by virtual screening and molecular dynamics simulations

Chuanming Zhang 1
Chuanming Zhang
Chao Zhang 2
Chao Zhang
Yanli Meng 2
Yanli Meng
Tai Li 2
Tai Li
Zhe Jin 2
Zhe Jin
Shicheng Hou 2
Shicheng Hou
Chun Hu 2
Chun Hu
Published 2022-04-29
CommunicationVolume 32, Issue 3, 334-335
3
Share
Cite this
GOST
 | 
Cite this
GOST Copy
Zhang C. et al. Identification of natural compounds targeting SARS-CoV-2 Mpro by virtual screening and molecular dynamics simulations // Mendeleev Communications. 2022. Vol. 32. No. 3. pp. 334-335.
GOST all authors (up to 50) Copy
Zhang C., Zhang C., Meng Y., Li T., Jin Z., Hou S., Hu C. Identification of natural compounds targeting SARS-CoV-2 Mpro by virtual screening and molecular dynamics simulations // Mendeleev Communications. 2022. Vol. 32. No. 3. pp. 334-335.
RIS
 | 
Cite this
RIS Copy
TY - JOUR
DO - 10.1016/j.mencom.2022.05.013
UR - https://mendcomm.colab.ws/publications/10.1016/j.mencom.2022.05.013
TI - Identification of natural compounds targeting SARS-CoV-2 Mpro by virtual screening and molecular dynamics simulations
T2 - Mendeleev Communications
AU - Zhang, Chuanming
AU - Zhang, Chao
AU - Meng, Yanli
AU - Li, Tai
AU - Jin, Zhe
AU - Hou, Shicheng
AU - Hu, Chun
PY - 2022
DA - 2022/04/29
PB - Mendeleev Communications
SP - 334-335
IS - 3
VL - 32
ER -
BibTex
 | 
Cite this
BibTex (up to 50 authors) Copy
@article{2022_Zhang,
author = {Chuanming Zhang and Chao Zhang and Yanli Meng and Tai Li and Zhe Jin and Shicheng Hou and Chun Hu},
title = {Identification of natural compounds targeting SARS-CoV-2 Mpro by virtual screening and molecular dynamics simulations},
journal = {Mendeleev Communications},
year = {2022},
volume = {32},
publisher = {Mendeleev Communications},
month = {Apr},
url = {https://mendcomm.colab.ws/publications/10.1016/j.mencom.2022.05.013},
number = {3},
pages = {334--335},
doi = {10.1016/j.mencom.2022.05.013}
}
MLA
Cite this
MLA Copy
Zhang, Chuanming, et al. “Identification of natural compounds targeting SARS-CoV-2 Mpro by virtual screening and molecular dynamics simulations.” Mendeleev Communications, vol. 32, no. 3, Apr. 2022, pp. 334-335. https://mendcomm.colab.ws/publications/10.1016/j.mencom.2022.05.013.

Keywords

COVID-19
molecular docking
molecular dynamics
natural compounds
SARS-CoV-2 inhibitors
SARS-CoV-2 Mpro

Abstract

The SARS-CoV-2 main protease (Mpro) has been chosen as a conserved molecular target to develop broad-spectrum antiviral drugs. Using molecular docking and molecular dynamics (MD) simulations, a total of 5600 natural compounds available for virtual screening were tested to identify potential inhibitors of SARS-CoV-2 Mpro. As a result, three natural compounds (pentagalloylglucose, malonylawobanin and gnetin E dihydride) were found to be potential inhibitors of SARS-CoV-2, which confirms the theoretical and practical significance of this approach for the design of SARS-CoV-2 inhibitors.

References

2.
Origin and evolution of pathogenic coronaviruses
Cui J., Li F., Shi Z.
Nature Reviews Microbiology, 2018
3.
SARS and MERS: recent insights into emerging coronaviruses
de Wit E., van Doremalen N., Falzarano D., Munster V.J.
Nature Reviews Microbiology, 2016
4.
WHO Coronavirus (COVID-19) Dashboard, World Health Organization, February 18, 2022. https://covid19.who.int/.
5.
Discovery of small molecule inhibitors through pharmacophore modeling, molecular docking, molecular dynamics simulation and experimental validation against myeloid cell leukemia-1 (Mcl-1)
Suleiman M.R., Wang H., Huang D., Wang H., Joseph J., Huang T., Zhang F., Wang J., Cheng M.
Journal of Biomolecular Structure and Dynamics, 2020
7.
Baricitinib as potential treatment for 2019-nCoV acute respiratory disease
Richardson P., Griffin I., Tucker C., Smith D., Oechsle O., Phelan A., Rawling M., Savory E., Stebbing J.
The Lancet, 2020
9.
Drug repurposing for coronavirus (COVID-19): in silico screening of known drugs against coronavirus 3CL hydrolase and protease enzymes
Elmezayen A.D., Al-Obaidi A., Şahin A.T., Yelekçi K.
Journal of Biomolecular Structure and Dynamics, 2020
10.
Structure of the RNA-dependent RNA polymerase from COVID-19 virus
Gao Y., Yan L., Huang Y., Liu F., Zhao Y., Cao L., Wang T., Sun Q., Ming Z., Zhang L., Ge J., Zheng L., Zhang Y., Wang H., Zhu Y., et. al.
Science, 2020
11.
One severe acute respiratory syndrome coronavirus protein complex integrates processive RNA polymerase and exonuclease activities
Subissi L., Posthuma C.C., Collet A., Zevenhoven-Dobbe J.C., Gorbalenya A.E., Decroly E., Snijder E.J., Canard B., Imbert I.
Proceedings of the National Academy of Sciences of the United States of America, 2014
12.
Identification of novel proteolytically inactive mutations in coronavirus 3C‐like protease using a combined approach
Zhou J., Fang L., Yang Z., Xu S., Lv M., Sun Z., Chen J., Wang D., Gao J., Xiao S.
FASEB Journal, 2019
15.
In silico insight into voltage-gated sodium channel 1.7 inhibition for anti-pain drug discovery
Wang M., Li W., Wang Y., Song Y., Wang J., Cheng M.
Journal of Molecular Graphics and Modelling, 2018
18.
Structure of Mpro from SARS-CoV-2 and discovery of its inhibitors
Jin Z., Du X., Xu Y., Deng Y., Liu M., Zhao Y., Zhang B., Li X., Zhang L., Peng C., Duan Y., Yu J., Wang L., Yang K., Liu F., et. al.
Nature, 2020
19.
Virtual identification of novel PPARα/γ dual agonists by scaffold hopping of saroglitazar
Jia W., Jing Z., Liu X., Feng X., Liu Y., Wang S., Xu W., Liu J., Cheng X.
Journal of Biomolecular Structure and Dynamics, 2017
20.
Identification of novel PI3Kδ inhibitors by docking, ADMET prediction and molecular dynamics simulations
Liu Y., Feng X., Jia W., Jing Z., Xu W., Cheng X.
Computational Biology and Chemistry, 2019
21.
In Silico Exploration of the Molecular Mechanism of Cassane Diterpenoids on Anti-inflammatory and Immunomodulatory Activity
Wang Y., Hu B., Peng Y., Xiong X., Jing W., Wang J., Gao H.
Journal of Chemical Information and Modeling, 2019